Keros Therapeutics, Inc. (KROS)
10.75
+0.25
(+2.38%)
USD |
NASDAQ |
Jun 04, 15:34
Keros Therapeutics EPS Diluted (Quarterly) : -1.208 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | -0.034 |
| Sarepta Therapeutics, Inc. | 2.878 |
| Insmed, Inc. | -0.7591 |
| United Therapeutics Corp. | 5.824 |
| Enanta Pharmaceuticals, Inc. | -0.4508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.71M |
| Revenue (Quarterly) | 0.367M |
| Total Expenses (Quarterly) | 24.08M |
| Enterprise Value | -57.99M |
| Gross Profit Margin (Quarterly) | -9.81% |
| Profit Margin (Quarterly) | -6.46K% |
| Earnings Yield | -27.96% |
| Normalized Earnings Yield | -27.94 |